Moderna Newsroom

UBS Group has lowered the Target Price for Moderna to 96 dollars.

Gelonghui FinanceJan 9 17:40

Moderna Analyst Ratings

BenzingaJan 8 23:05

Bernstein Maintains Moderna(MRNA.US) With Hold Rating, Maintains Target Price $55

Futu NewsJan 8 20:38

UBS Maintains Moderna(MRNA.US) With Buy Rating, Cuts Target Price to $96

Futu NewsJan 8 20:34

Argus Research Downgrades Moderna(MRNA.US) to Hold Rating

Futu NewsDec 19, 2024 01:31

Moderna Analyst Ratings

BenzingaDec 19, 2024 00:16

Argus Research Downgrades Moderna(MRNA.US) to Hold Rating

Futu NewsDec 18, 2024 20:32

BofA Securities Initiates Moderna(MRNA.US) With Sell Rating, Announces Target Price $41

Futu NewsDec 11, 2024 16:31

Moderna Analyst Ratings

BenzingaDec 10, 2024 20:31

B of A Securities Reinstates Underperform on Moderna, Announces $41 Price Target

BenzingaDec 10, 2024 20:31

Piper Sandler Maintains Moderna(MRNA.US) With Buy Rating, Maintains Target Price $69

Futu NewsDec 6, 2024 20:33

Moderna Analyst Ratings

BenzingaNov 26, 2024 22:42

JPMorgan Adjusts Price Target on Moderna to $45 From $59, Maintains Underweight Rating

MT NewswiresNov 26, 2024 18:35

Jefferies Downgrades Moderna(MRNA.US) to Hold Rating, Cuts Target Price to $50

Futu NewsNov 23, 2024 01:31

Baptista Upgrades Moderna to Buy, Price Target at $48

MT NewswiresNov 20, 2024 18:18

BioNTech Stock Has Been Hit Hard Since RFK Jr.'s Nomination. Why This Analyst Upgraded It. -- Barrons.com

Barron'sNov 20, 2024 00:57

Berenberg Bank Initiates Moderna(MRNA.US) With Hold Rating, Announces Target Price $42

Futu NewsNov 19, 2024 18:34

Berenberg Bank Initiates Moderna(MRNA.US) With Hold Rating, Announces Target Price $42

Futu NewsNov 19, 2024 16:43

Moderna Analyst Ratings

BenzingaNov 18, 2024 22:13

HSBC Upgrades Moderna to Buy From Hold, Adjusts Price Target to $58 From $82

MT NewswiresNov 18, 2024 18:47